Skip to main content
. 2020 Dec 15;9(12):e21772. doi: 10.2196/21772

Table 3.

Overview of included constructs, measurements, and sources.

Constructs Measurements and sources Purpose
Baseline (t=0): directly before the decision aid

Demographics Age, gender, education [52] Sample description, attrition analyses, covariate(s) in (main) analyses

Smoking behavior Smoking status, motivation to quit, type of tobacco products, amount of tobacco consumption, amount of past cessation attempts, and cessation assistance utilization in the past 6 months [52] Sample description, attrition analyses

Nicotine dependence Revised Fagerström Test for Nicotine Dependence (FTND-R) [53] Sample description, attrition analyses, covariate in (main) analyses

Productivity loss iMTA Productivity Cost Questionnaire (iPCQ) [54] Economic evaluation

Health care utilization Contacts with health care professionals (plus frequency) in the past 6 months, cessation assistance utilization (plus frequency) in the past 6 months [55] Economic evaluation

Quality of life ICEpop CAPability measure for Adults (ICECAP-A) [56] Economic evaluation

Stages of decision making Stage of Decision Making [57] Sample description, attrition analyses, process information, covariate in (main) analyses
Follow-up (t=1): directly after the decision aid

Stages of decision making Stage of Decision Making [57] Sample description, process information

Decision Decision after having used the decision aid (DA), not yet implemented Sample description, process information

Decision-making process Decisional conflict scale [58], first item from the Preparation for Decision Making Scale [59]

Hypothesis testing, H4 (decisional conflict scale [58]); process information and additional studies (see “Data Analysis”)

Knowledge Self-developed knowledge scale [60]

Additional studies (see “Data Analysis”)

Perceived autonomy support The Virtual Care Climate Questionnaire [47] Additional studies (see “Data Analysis”)

Perceived competence Perceived competence scale [48] Additional studies (see “Data Analysis”)

Evaluation questions Regarding attention, clarity, satisfaction, and one open question Process information

Recruitment channels N/Aa Recruitment monitoring and analyses
Follow-up (t=2): 1 month after baseline


Decision implementation Implemented decision (choice) after having used the DA Hypothesis testing, H2a and H3a

Smoking (cessation) behavior Prolonged abstinence; 7-day point prevalence abstinence; for users that did not successfully stop: type of tobacco products and amount of tobacco consumption [52] Hypothesis testing, H1a (7-day point prevalence abstinence [52]); additional studies (see “Data Analysis”)

Stages of decision making Stage of Decision Making [57] Sample description, process information

Knowledge Self-developed knowledge scale [60] Additional studies (see “Data Analysis”)
Follow-up (t=3): 6 months after baseline

Decision implementation Implemented decision (choice) after having used the DA Hypothesis testing, H2b and H3b

Smoking (cessation) behavior Prolonged abstinence; 7-day point prevalence abstinence; for users that did not successfully stop: type of tobacco products and amount of tobacco consumption [52] Hypothesis testing, H1b and H3a (7-day point prevalence abstinence [52]); additional studies (see “Data Analysis”)

Productivity loss iPCQ [54] Economic evaluation

Health care utilization Contacts with health care professionals (plus frequency) in the past 6 months, cessation assistance utilization (plus frequency) in the past 6 months [55] Economic evaluation

Quality of life ICECAP-A [56] Economic evaluation

Decisional regret Decision regret scale [61] Additional studies (see “Data Analysis”)
Follow-up (t=4): 12 months after baseline

Decision implementation Implemented decision (choice) after having used the DA Hypothesis testing, H2c

Smoking (cessation) behavior Prolonged abstinence; 7-day point prevalence abstinence; for users that did not successfully stop: type of tobacco products and amount of tobacco consumption [52] Hypothesis testing, H1c and H3b (7-day point prevalence abstinence [52]); additional studies (see “Data Analysis”)

Productivity loss iPCQ [54] Economic evaluation

Health care utilization Contacts with health care professionals (plus frequency) in the past 6 months, cessation assistance utilization (plus frequency) in the past 6 months [55] Economic evaluation

Quality of life ICECAP-A [56] Economic evaluation

Decisional regret Decision regret scale [61] Additional studies (see “Data Analysis”)

Evaluation questions Regarding perceived decision support Process information

aN/A: not applicable.